# Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

> **NCT00735501** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 314 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT00735501
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 314 (ACTUAL)
- **Last updated:** 2014-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735501, "Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00735501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*